DoreDD, SeegerJD, ArnoldCK. Use of a claims-based drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin2009; 25:1019–27.
4.
GargR, ChenW, PendergrassM. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes Care2010; 33:2349–54.